Proteomic Analysis of Patients Undergoing Bariatric Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversidade Federal de Pernambuco

About this trial

The expression of proteins in the blood of obese individuals is different from the expression of proteins in healthy individuals, and is also different in individuals after bariatric surgery. Therefore, this research aims to better understand protein expression in patients indicated for surgical treatment of obesity, evaluating the pre-operative and post-operative status. The objective of this research is to better understand protein expression in patients indicated for surgical treatment of obesity, evaluating the pre-operative and post-surgery status.

Eligibility criteria

Qualifiers

patients over 18 years of age with a BMI above 35 kg/m² associated with comorbidity or BMI above 40 kg/m² without comorbidities,

Disqualifiers

Patients with a previous history of cancer;

Underage patients

Patients with other diseases predisposing to the development of cancer: cirrhosis, ulcerative colitis, Barrett's esophagus, etc.

Patients who have previously undergone bariatric surgery;

Trial design

Treatments tested in this trial

  • bariatric surgery

Treatment groups

103 Participants
are divided into 7 treatment groups

7

Treatment groups

See each treatment group below.